Drug Type Gene therapy |
Synonyms RZ 001, RZ-001, RZ001 |
Target |
Mechanism TERT modulators(Telomerase reverse transcriptase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationFast Track (US), Orphan Drug (US) |
Start Date01 Oct 2023 |
Sponsor / Collaborator |
Start Date29 Jul 2022 |
Sponsor / Collaborator |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Phase 2 | - | 01 Oct 2023 | |
Hepatocellular Carcinoma | Phase 2 | KR | 13 Jul 2022 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |